FdaApplication

NDA 219500

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCORSTASIS THERAPEUTICS INC
application_typeNDA
approval_date2025-09-12

Products (1)

ProductActive ingredientStrengthDosage form
ENBUMYSTBUMETANIDE0.5MG/SPRAYSPRAY;NASAL

1 product